Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19 Read more
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates Read more
Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments Read more
iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases Read more
Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim Read more
Ferring Receives U.S. FDA Approval for REBYOTA (fecal microbiota, live-jslm) – A Novel First-in-Class Microbiota-Based Live Biotherapeutic Read more
Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer Read more